FDA Inspection 1206678 — NeuroVention, LLC
The FDA completed an inspection of NeuroVention, LLC on May 31, 2023 in Daytona Beach, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 31, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Daytona Beach, FL (United States)